Gerhard Winter was born in 1959, studied Pharmacy at the University of Heidelberg from 1977 until 1982 with a scholarship from the Studienstiftung . In 1983 he received the German Approbation and started a Ph. D. thesis under the supervision of Prof. Stricker in the area of transdermal absorption simulations.
He finished the Ph.D. in 1987 with summa cum laude and accepted a position at Merck in Darmstadt leading a laboratory for solid dosage form development. In 1988 he joined Boehringer Mannheim, later Roche where he stayed until 1999. During this time Dr. Winter was responsible for parenteral and liquid dosage form development including every development step from preformulation, to stability studies and clinical supplies to scale up, production transfer and dossier submission.
He led a large scale aseptic pilot plant to supply worldwide clinical studies with lyophilisates and sterile solutions. His special interest was focused on protein and peptide formulations, freeze drying and parenteral drug delivery systems. He was involved in the development of major drug products like EPO, Reteplase and Ibandronate.
In 1999 G.Winter was appointed as a full professor for Pharmaceutical Technology and Biopharmaceutics at the University of Munich , Center for Drug Research, where he is currently working on protein stabilisation, parenteral dosage form technology, novel drying technologies, drug delivery systems and colloidal drug formulations.
Prof. Winter has issued about 40 patents and 170 publications in his research field, about 60 theses have been finished under his supervision. He is member of many scientific societies, editorial advisory boards of several scientific journals and scientific advisory boards of research companies.
In 2008 he co-founded Coriolis Pharma GmbH, Martinsried, together with former Ph.D. students to provide the biotec industry with formulation and analytical services.